InvestorsHub Logo
Followers 48
Posts 2221
Boards Moderated 1
Alias Born 01/28/2013

Re: None

Wednesday, 03/18/2015 9:28:27 PM

Wednesday, March 18, 2015 9:28:27 PM

Post# of 24848
The bottom line that I think retail shareholders are still failing to see is that the single biggest thing that can impact the sp in a material and positive manner is for BS Schneiderman to evict the unnecessary middlemen, including getting rid of Adam Brosius (who, like JOSEPH ZAMPETTI, was paid by SCRC to promote the stock, and has zero prior background/experience in pharma to boot), and bringing selling expenses back down to a reasonable level that is no higher than 50%. The positive impact of doing so will easily eclipse the impact of PIMD and the Diabetic Program bringing in $10M apiece.

Don't believe me? Just look at the ridiculous $400k net income being projected from Q1'15 projected total revenues of $9.5M. This translates to only a measly 4.2% net income rate. Q3'14 was 11.9%.

Consider this: At $400k net income per quarter, this translates to $1.6M per year. If Main Ave were to report $24M in revenues this year (which translates to approx $2M/month), this means that if selling expenses were back at the 45% level they were during Q1'14 and Q2'14 instead of the bloated 65% it shot up to in Q3'14, this reduction in selling expenses BY ITSELF would contribute another $4.8M DIRECTLY INTO THE BOTTOM LINE AS ADDITIONAL NET INCOME.

IN ESSENCE, NET INCOME -- AND EPS -- WOULD TRIPLE.

All this continued talk of immaterial side revenue streams are nothing more than red herrings and mis-direction at this time, while BS Schneiderman continues to leave the barnyard door open for select hogs/cronies to gorge themselves at the trough, sending only the scraps downstream in the form of piddly net earnings for the other shareholders.